I doubt that there will be another capital raising anytime soon....

I doubt that there will be another capital raising anytime soon. I imagine the company will be looking to raise non-dilutive capital from up-front payments on the two partnering deals they hope to conclude in the near future. We know Invion is in talks on a partnering deal for Cpn10 and, if the final results of the smoking cessation trial are as good as the interim results, presumably they will soon be in talks on an oral nadolol deal too.

The share price could easily get above 2c just on the basis of positive results from the smoking cessation trial, which are expected later this month, and then rise significantly from there - depending on how good the partnering deals are.